BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 234 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $380 | +5.6% | 53,640 | +4.9% | 0.00% | +50.0% |
| Q2 2023 | $360 | -24.8% | 51,121 | -11.0% | 0.00% | -33.3% |
| Q1 2023 | $479 | -25.6% | 57,430 | +2.4% | 0.00% | -40.0% |
| Q4 2022 | $644 | -99.9% | 56,078 | -8.1% | 0.01% | -16.7% |
| Q3 2022 | $769,000 | +153.0% | 61,051 | +112.4% | 0.01% | +200.0% |
| Q2 2022 | $304,000 | -48.6% | 28,741 | -20.9% | 0.00% | -33.3% |
| Q1 2022 | $591,000 | +24.9% | 36,342 | +6.4% | 0.00% | +50.0% |
| Q4 2021 | $473,000 | +19.1% | 34,141 | +23.6% | 0.00% | 0.0% |
| Q3 2021 | $397,000 | +9.7% | 27,631 | +20.5% | 0.00% | 0.0% |
| Q2 2021 | $362,000 | +82.8% | 22,923 | +17.8% | 0.00% | +100.0% |
| Q1 2021 | $198,000 | +67.8% | 19,465 | +23.1% | 0.00% | 0.0% |
| Q4 2020 | $118,000 | +45.7% | 15,813 | +12.5% | 0.00% | 0.0% |
| Q2 2018 | $81,000 | -22.1% | 14,060 | -35.4% | 0.00% | 0.0% |
| Q1 2018 | $104,000 | -32.9% | 21,773 | -31.1% | 0.00% | 0.0% |
| Q4 2017 | $155,000 | +573.9% | 31,595 | +284.2% | 0.00% | – |
| Q2 2016 | $23,000 | +4.5% | 8,224 | +8.1% | 0.00% | – |
| Q1 2016 | $22,000 | -60.0% | 7,609 | +42.5% | 0.00% | – |
| Q4 2015 | $55,000 | -32.1% | 5,341 | -24.8% | 0.00% | -100.0% |
| Q3 2015 | $81,000 | +145.5% | 7,106 | +217.5% | 0.00% | – |
| Q2 2015 | $33,000 | +106.2% | 2,238 | +28.5% | 0.00% | – |
| Q1 2015 | $16,000 | -23.8% | 1,742 | +0.2% | 0.00% | – |
| Q4 2014 | $21,000 | +5.0% | 1,739 | -14.0% | 0.00% | – |
| Q3 2014 | $20,000 | -4.8% | 2,022 | +22.0% | 0.00% | – |
| Q2 2014 | $21,000 | +16.7% | 1,657 | 0.0% | 0.00% | – |
| Q1 2014 | $18,000 | +50.0% | 1,657 | +1.5% | 0.00% | – |
| Q4 2013 | $12,000 | – | 1,633 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 864,916 | $13,674,000 | 13.71% |
| Sarissa Capital Management LP | 4,261,000 | $67,366,000 | 5.36% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,920,733 | $30,367,000 | 4.18% |
| HealthCor Management, L.P. | 3,248,100 | $51,352,000 | 2.05% |
| Parkman Healthcare Partners LLC | 351,961 | $5,565,000 | 1.22% |
| Bain Capital Public Equity Management II, LLC | 1,560,730 | $24,675,000 | 1.06% |
| Baker Brothers Advisors | 12,710,818 | $200,958,000 | 0.88% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,835,000 | $44,821,000 | 0.80% |
| Biondo Investment Advisors, LLC | 265,840 | $4,203,000 | 0.72% |
| EAM Global Investors LLC | 157,065 | $2,483,000 | 0.69% |